Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Psychedelic/Assisted Therapies

Recent news which mentions Psychedelic/Assisted Therapies

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Orange Photonics: New High-Tech Testing For Psychedelic Products
Tags News Psychedelics Benzinga
From Benzinga
Small Pharma's Q2 2024 Financial Highlights Ahead Of Cybin Merger For Global DMT Business
Tickers CYBN DMT DMTTF
Tags CYBN Psychedelic/Assisted Therapies Market News
From Benzinga
Congress Halts Hearing On Psychedelics & Veterans As House Speaker Drama Continues
Tags News Veterans Affairs Management
From Benzinga
New Survey Suggests Psilocybin Eases Psychological Distress From Childhood Trauma
Tags Cannabis Markets Market News
From Benzinga
EXCLUSIVE: Reason For Hope On Veteran Group Efforts, Comments To FDA & 2023 Expectations
Tags Reason for Hope Management News
From Benzinga
Lucy Scientific's Fiscal Year: Operating Expenses Rise As Accumulated Deficit Hits Over $44M
Tickers LSDI
Tags Psychedelics News LSDI
From Benzinga
Psyched: FDA Warning, DEA's Telehealth Extension, CA Gov's Veto, Congress On Kratom, M&As & More
Tickers ATAI CMPS CYBN DMTTF
Tags DRUG PSIL U/S/ Food and Drug Administration
From Benzinga
U.K.'s Prof. David Nutt Ranked World's Top Psychopharmacologist: More On His Contributions & Advocacy
Tickers AWKNF
Tags Benzinga Mention of Honor Drug Science
From Benzinga
Dem Presidential Candidate Calls For Universal Healthcare, Including Psychedelics Therapy
Tags News Psychedelic/Assisted Therapies Cannabis
From Benzinga
Cybin And Small Pharma Shareholders Green Light Acquisition Resolution: Results & Expected Dates
Tickers CYBN DMTTF
Tags M&A News Short/Acting Psychedelics
From Benzinga
Pioneering Hope: Inside The Veteran's Organization Advancing Psychedelics Reform Policy
Tags Exclusives News Reason for Hope
From Benzinga
EXCLUSIVE: Understanding Real Estate For Psychedelic Treatments Boosted By Geospatial Mapping
Tickers AAPL IBM
Tags Real Estate Benzinga IBM
From Benzinga
EXCLUSIVE: The Need To Enhance Psychedelic Therapy Infrastructure, Data-Driven Solutions
Tags Psychedelic/Assisted Therapies HealingMaps Markets
From Benzinga
Maine's Portland Leads Drug Policy Reform, Decriminalizing Psychedelic Plants And Fungi
Tags Benzinga Legal Management
From Benzinga
Decoding Insurance Reimbursement For Psychedelic-Assisted Therapy With BrainFutures Guide
Tags Psychedelics BrainFutures News
From Benzinga
Atai Life Sciences Completes Phase 1 Clinical Study Of Oral Film DMT Formulation
Tickers ATAI
Tags Psychedelics Benzinga News
From Benzinga
Cybin Completes Dosing In Phase 2 Study Of CYB003 For Major Depressive Disorder Treatment
Tickers CYBN
Tags Market News Markets Cannabis
From Benzinga
Steve Cohen Keeps Betting On Biopharma With Purchase Of 119M+ Bionomics Shares
Tickers BNOX CYBN MRK
Tags MRK Psychedelics Biopharma
From Benzinga
Insider's Look At Psychedelics Industry On Risk Management, Gray Market & Cannabis Industry
Tags AlphaRoot Health Insurance Interview
From Benzinga
GH Research's Psychedelic Drug Candidate For Depression Meets FDA: Clinical Program On Hold
Tickers GHRS
Tags Psychedelics News Investigational New Drug Application
From Benzinga
Gov Newsom Green Lights Medical Psychedelics If Rescheduled And New Marijuana Testing Rules
Tags Psychedelics Reform Cannabis Testing Psychedelics
From Benzinga
Psychedelic Therapy Providers: Risk Management Perspective From A Cannabis Insurance Specialist
Tags News Isaac Bock Psychedelics
From Benzinga
Argentina's Nacho Bottinelli On Psychedelics In Latin America: 'Brazil Opened A Giant Portal To Me'
Tags News Exclusives Psychedelics
From Benzinga
Psyched: DMT & SSRIs For Depression, MDMA Training, Negative Responses To Psychedelics & More
Tickers ATAI CMPS CYBN DMTTF
Tags Small Cap HUGE Market News
From Benzinga
Psychedelics Reform Update: Massachusetts, Pennsylvania, Maine, California, Michigan, Minnesota, Indiana
Tags Rumors Psychedelics Psychedelics Reform
From Benzinga
PharmaTher Is 'One Step Closer To Being A Ketamine Leader' Due To FDA Acceptance
Tickers PHRRF
Tags Health Care PHRRF Penny Stocks
From Benzinga
Cybin And Fluence Partner To Support EMBARK Training For Phase 3 CYB003 Trial For Depression
Tickers CYBN
Tags Guidance CYBN Global
From Benzinga
Depression Relief: Possible Therapy Boost With DMT & SSRIs, Per Small Pharma Clinical Results
Tickers CYBN DMTTF
Tags DMTTF Psychedelics major depressive disorder
From Benzinga
Defense Dept. Grants $1M To Yale & Transcend Therapeutics To Study PTSD Therapy
Tags PTSD treatment Yale University Benzinga
From Benzinga
Psyched: Steve Cohen Goes Big On Cybin, Fed Intervention On Psilocybin, Ketamine Insurance And More
Tickers ATAI CMPS CYBN DMTTF
Tags GHRS DMTTF NKE
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.